Abstract: A bracket anchor for fastening a facing to a supporting wall has a bracket head for fastening the bracket anchor to the supporting wall, a web plate, a support element for supporting the facing, and a pressure element for transmitting pressure from the bracket anchor to the supporting wall. The support element and the pressure element are secured to the web plate. The entire web plate is formed from a single plate of constant wall thickness. The web plate includes a tension strut and a compression strut which are connected to one another only at their ends facing the support element and at most over half of the projecting length of the bracket anchor.

Abstract: A bracket anchor for fastening a facing to a supporting wall has a bracket head for fastening the bracket anchor to the supporting wall, a web plate, a support element for supporting the facing, and a pressure element for transmitting pressure from the bracket anchor to the supporting wall. The support element and the pressure element are secured to the web plate. The entire web plate is formed from a single plate of constant wall thickness. The web plate includes a tension strut and a compression strut which are connected to one another only at their ends facing the support element and at most over half of the projecting length of the bracket anchor.

Abstract: The present invention provides topically administrable endoparasiticidal compositions comprising cyclic and open-chain depsipeptides consisting of amino acid and hydroxycarboxylic acid building blocks and containing 6 to 30 ring or chain atoms, their preparation and their use as endoparasiticides.

Abstract: The present invention relates to novel optionally substituted 8-cyano-1-cyclo-propyl-7-(2,8-diazabicyclo[4.3.

Abstract: Intermediates useful in the preparation of 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl-6-fluorol,4-dihydro-4-oxo-3-quinolinecarboxylic acids of the following structures are claimed.

Abstract: The present invention relates to novel injection and infusion solutions of the following composition:a) 0.1 to 20% by weight of enrofloxacin, based on the total weight of the solution, in the form of its salts with polyhydroxycarboxylic acids or amino acids or mixtures thereof,b) polyhydroxycarboxylic acids, amino acids or mixtures thereof in 0.1 to 5 molar excess, based on enrofloxacin;c) optionally 0.1 to 30% by weight of formulation aids, based on the total weight of the solution;d) water to 100% by weight.

Abstract: Disclosed are pyrido?3,2,1-i,j!?3,1!benzoxazine compounds of the formula (I): ##STR1## wherein z represents a radical having the formula: ##STR2## wherein B represents --CH.sub.2 --, --O-- or a direct bond; and the other variables in formula (I) and Z are as described herein. The compounds have antibacterial properties and also disclosed are antibacterial compositions containing them and methods of using them to prevent or combat bacterial infections. Methods for preparing the compounds are also disclosed.

Abstract: The present invention relates to new thiazolo?3,2-a!quinoline and thiazolo?3,2-a!naphthyridine derivatives of the general formula (I) ##STR1## in which R.sup.1, R.sup.2, Z and X have the meaning indicated in the description, processes for their preparation and their use in antibacterial compositions.

Abstract: The present invention relates to new 8-amino-10-(azabicycloalkyl)-pyrido?1,2,3-d,e!?1,3,4!benzoxadiazine derivatives of the general formula (I) ##STR1## in which the radicals R.sup.1 to R.sup.4, Z and X.sup.1 have the meaning given in the description, processes for their preparation and their use in antibacterial compositions.

Abstract: The invention relates to new 5-vinyl- and 5-ethinylquinolone- and -naphthyridonecarboxylic acids, to processes for their preparation, and to antibacterial compositions and feed additives containing them.

Abstract: The present invention relates to 1,9-bridged thiazolo[3,2-a]quinoline derivatives of the general formula (I) ##STR1## in which the substituents Z, X, R.sup.1 have the meaning given in the description, to processes for their preparation and to their use in antibacterial compositions.

Abstract: The invention relates to new 5-vinyl- and 5-ethinyl-quinolone- and -naphthyridonecarboxylic acids, to processes for their preparation, and to antibacterial compositions and feed additives containing them.

Abstract: Novel bactericidal pyrido[1,2,3-d,e,][1,3,4]benzoxadiazine derivatives of the formula (I) ##STR1## in which R.sup.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl or halogen,R.sup.2 independently of R.sup.1 is hydrogen or methyl,R.sup.3 is hydrogen or C.sub.1 -C.sub.4 -alkyl,R.sup.4 is hydrogen, C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)-methyl,X.sup.